Page last updated: 2024-09-03

n-formyl-13-dihydrocarminomycin and Cardiovascular Diseases

n-formyl-13-dihydrocarminomycin has been researched along with Cardiovascular Diseases in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Buckley, JD; Carter, S; Coates, AM; Fraysse, F; Hill, AM; Mead, LC; Rogers, GB; Tan, SY; Wong, HY; Yandell, C1

Trials

1 trial(s) available for n-formyl-13-dihydrocarminomycin and Cardiovascular Diseases

ArticleYear
Almonds vs. carbohydrate snacks in an energy-restricted diet: Weight and cardiometabolic outcomes from a randomized trial.
    Obesity (Silver Spring, Md.), 2023, Volume: 31, Issue:10

    Topics: Adult; Aged; Cardiovascular Diseases; Glucose; Humans; Lipoproteins, LDL; Middle Aged; Prunus dulcis; Snacks

2023